My thoughts on the OLE is that the FDA is going to want as much data as they can get when this goes for EUA and FULL approval. Once it is released with an EUA they can't get anymore relevant data. At least the OLE will have some usable data if they are collecting it.

On a similar note it would be really nice to know how many more patients were added under the OLE and the Eind extensions.